Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Recruiting

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

NCT07550010

Conditions: Cervical Cancer Screening Methods, Cervical Intraepithelial Neoplasia Grade 2 (CIN2), Communicable Diseases, +13 more
Locations: Centre Hospitalier Universitaire de Yaoundé Yaoundé, Cameroon

Yaoundé University Teaching Hospital (CHU) Yaoundé, Cameroon

View Trial Details

Recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

NCT06287229

Conditions: B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +39 more
Locations: Johns Hopkins Hospital East Baltimore Baltimore, Maryland, United States

View Trial Details

Recruiting

Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma

NCT07097363

Conditions: B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

NCT05583708

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States

University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Recruiting

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

NCT04544592

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, +20 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

View Trial Details

Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

NCT06947928

Conditions: Adenocarcinoma, Advanced Or Metastatic Merkel Cell Carcinoma, Carcinoma, +22 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Stanford Health Care - Skin Cancer Program Stanford, California, United States

University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States

View all 18 locations

View Trial Details

Recruiting

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts

NCT07534865

Conditions: DNA Virus Infections, Infections, Papillomavirus Infections, +7 more
Locations: Infrared Hyperthermia Device Shenyang, China

View Trial Details

Recruiting

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

NCT04491370

Conditions: B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +27 more
Locations: New York Medical Center Valhalla, New York, United States

View Trial Details

Recruiting

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

NCT07523555

Conditions: BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Tumor Virus Infections

Tumor Virus Infections trial results

Related conditions